Bsoul Remarh, Simonsen Anja H, Frederiksen Kristian S, Svenstrup Kirsten, Bech Sara, Salvesen Lisette, Hejl Anne-Mette, Rossi Marcello, Parchi Piero, Lund Eva L, Areškevičiūtė Aušrinė
Danish Reference Center for Prion Diseases, Department of Pathology, Copenhagen University Hospital, Copenhagen, Denmark.
Danish Dementia Research Centre, Copenhagen University Hospital, Copenhagen, Denmark.
PLoS One. 2025 Jun 25;20(6):e0326568. doi: 10.1371/journal.pone.0326568. eCollection 2025.
Seeding amplification assays, specifically the Real-Time Quaking-Induced Conversion method (RT-QuIC), have shown great diagnostic potential for α-synucleinopathies. Numerous research groups have demonstrated the method's high sensitivity and specificity using cerebrospinal fluid (CSF) samples and various RT-QuIC workflows. However, establishing a uniform and stably performing RT-QuIC protocol remains challenging. To address this, we established an RT-QuIC protocol with a Universal Control Fluid (UCF), which is simple to adopt, performs stably, and allows uniform preparation of both sample and control reactions. Firstly, we adapted and established a published 48-hour RT-QuIC protocol, including the in-house production of recombinant α-synuclein (rec α-syn), and evaluated its sensitivity and specificity through a blinded screening of an 81 CSF sample cohort consisting of Parkinson's disease (PD), dementia with Lewy bodies (DLB), Alzheimer's disease, motor neuron disease, multiple system atrophy, unidentified neurodegenerative diseases, and healthy controls. Additionally, we tested all CSF samples in three volumes to determine which volume provides the best diagnostic accuracy. The established RT-QuIC performs nearly equally well with 7 µL and 15 µL added CSF, resulting in 94% and 94.5% diagnostic accuracy, respectively. Secondly, we developed a UCF solution and tested its performance with the established RT-QuIC protocol. Results indicate that UCF, used in defined volume and concentration, standardizes the preparation of both sample and control reactions without compromising the assay's diagnostic accuracy and provides a stabilizing environment for the reactions, ensuring higher reproducibility. The established RT-QuIC protocol for pathologic α-synuclein detection in PD and DLB CSF samples is highly sensitive (92-96%) and specific (93-96%). Therefore, it is important that its adoption in clinical laboratories is uncomplicated and uniform. RT-QuIC with UCF simplifies, standardizes, and stabilizes the assay's performance and, thus, could be recommended as a standard protocol for accurate detection of α-synucleinopathies.
接种扩增检测方法,特别是实时颤抖诱导转化法(RT-QuIC),已显示出对α-突触核蛋白病具有巨大的诊断潜力。众多研究小组已使用脑脊液(CSF)样本和各种RT-QuIC工作流程证明了该方法的高灵敏度和特异性。然而,建立一个统一且性能稳定的RT-QuIC方案仍然具有挑战性。为解决这一问题,我们建立了一种使用通用对照液(UCF)的RT-QuIC方案,该方案易于采用,性能稳定,且能统一制备样本和对照反应。首先,我们调整并建立了一个已发表的48小时RT-QuIC方案,包括在内部生产重组α-突触核蛋白(rec α-syn),并通过对一个由帕金森病(PD)、路易体痴呆(DLB)、阿尔茨海默病、运动神经元病、多系统萎缩、不明神经退行性疾病和健康对照组成的81个脑脊液样本队列进行盲法筛查,评估其灵敏度和特异性。此外,我们对所有脑脊液样本进行了三种体积的测试,以确定哪种体积能提供最佳诊断准确性。所建立的RT-QuIC在加入7微升和15微升脑脊液时表现几乎同样出色,诊断准确率分别为94%和94.5%。其次,我们开发了一种UCF溶液,并使用所建立的RT-QuIC方案测试其性能。结果表明,以规定体积和浓度使用的UCF可使样本和对照反应的制备标准化,同时不影响检测的诊断准确性,并为反应提供稳定环境,确保更高的可重复性。所建立的用于检测PD和DLB脑脊液样本中病理性α-突触核蛋白的RT-QuIC方案具有高度敏感性(92 - 96%)和特异性(93 - 96%)。因此,在临床实验室中采用该方案简便且统一非常重要。带有UCF的RT-QuIC简化、标准化并稳定了检测性能,并因此可被推荐为准确检测α-突触核蛋白病的标准方案。